Health Science Journal

  • ISSN: 1108-7366
  • Journal h-index: 51
  • Journal CiteScore: 10.69
  • Journal Impact Factor: 9.13
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Awards Nomination 20+ Million Readerbase
Indexed In
  • Genamics JournalSeek
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • CINAHL Complete
  • Scimago
  • Electronic Journals Library
  • Directory of Research Journal Indexing (DRJI)
  • EMCare
  • OCLC- WorldCat
  • University Grants Commission
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • Google Scholar
  • Secret Search Engine Labs
Share This Page

Effectiveness of High-dose Steroids Treatment in Patients with Severe Presentation of Covid -19

XX Congresso Regionale FADOI CAMPANIA: Non ci siamo mai fermati
Italy 2021

Capasso F*, Ascione T, Bresciani A, Cannavale A, Cavallaro R and Morella P

Department of Internal Medicine, AORN Cardarelli- Napoli, Italy
Infectious Diseases Service, AORN Cardarelli-Napoli, Italy

Posters & Accepted Abstracts: Health Sci J


Background and Aims: In the COVID 19 acute phase, low-dose steroids treatment has been proved to be effective, but studies on the effect of high-dose steroids are currently lacking. Here, we report our experience with high-dose steroids in a case-series of COVID-19 patients. Material and Methods: Patients admitted to the Unit of Internal Medicine of Cardarelli Hospital-Naples with severe COVID-19 presentation, defined by a P/F<250 and high CT score, with evidence of interstitial pneumonia receiving high-dose steroids therapy (Dexamethasone 20 mg/day for 5 days and 10 mg/day for other 5 days) were considered. For each case, we completed a case-report form including P/F ratio, radiologic score (24 fields score), calculated when high dose steroids were started and after 14 days. An unfavourable outcome was defined by intrahospital death. Results: Thirty-eight patients were included [Males 74%, median age 63 years (range 30-89)]. Comorbidities or high BMI were reported in 31 (82%) cases. Median radiologic score was 16 (range 10-23). After steroids were administered, we observed a significant improvement of P/F ratio (130 Vs 176, t=2.37, p=0.027) and of radiologic score. Mortality rate was 45%. Conclusions: High-dose steroids can be administered to patients with severe COVID-19, but do not affect mortality.